<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
      <PMID Version="1">35590115</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>19</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1434-9949</ISSN>
          <JournalIssue CitedMedium="Internet">
            <PubDate>
              <Year>2022</Year>
              <Month>May</Month>
              <Day>20</Day>
            </PubDate>
          </JournalIssue>
          <Title>Clinical rheumatology</Title>
          <ISOAbbreviation>Clin Rheumatol</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Gonococcal arthritis: case series of 58 hospital cases.</ArticleTitle>
        <ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-022-06208-w</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Extra-genital manifestations of gonococcal infection are rare (0.5-3%). Among them, gonococcal arthritis (GA) is the most frequent, accounting for 30-90% of disseminated infections. Our study aimed to describe all hospital cases of GA in Reunion Island, a French overseas territory.</AbstractText>
          <AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a retrospective, multicentric, observational study of all cases of certain, probable or possible GA from 2008 to 2020.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 58 cases of GA, mostly certain cases (n = 48). Sex ratio was balanced, but men were older than women (51 vs 27 years, p &lt; 0.001). A total of 41% had travelled abroad during the previous 3 months, mostly in Madagascar or South-East Asia. The most frequently infected joint was the knee, followed by ankle, wrist and fingers or carpal joints. Only 16% of cases had genital symptoms, but 50% had another extra-genital manifestation, mainly skin lesions (40%). Positivity rate of joint puncture was 91%, with a purulent liquid. Only 58% had a positive culture, and 33% had only a positive PCR. There was no 3GC-resistant strain. In comparison with gonococcal infection without arthritis, patients were older and had fewer genital but more extra-genital symptoms. On discharge 60% had persistent articular symptoms. GA represented 18% of all hospitalised septic arthritis cases with microbial identification in 2019.</AbstractText>
          <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GA is rare but it is important to make an early diagnosis and treat promptly, as joint destruction may be important, leading to persistent symptoms after discharge. PCR use in joint puncture is useful in cases with negative culture.</AbstractText>
          <CopyrightInformation>© 2022. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Moussiegt</LastName>
            <ForeName>Aurore</ForeName>
            <Initials>A</Initials>
            <Identifier Source="ORCID">0000-0003-4078-0358</Identifier>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, CHU Nord, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>François</LastName>
            <ForeName>Claire</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine and Infectious Disease Department, CH Ouest, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Belmonte</LastName>
            <ForeName>Olivier</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Bacteriology Department, CHU Nord, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Jaubert</LastName>
            <ForeName>Julien</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Bacteriology Department, CHU Sud, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Traversier</LastName>
            <ForeName>Nicolas</ForeName>
            <Initials>N</Initials>
            <AffiliationInfo>
              <Affiliation>Bacteriology Department, CHU Nord, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Picot</LastName>
            <ForeName>Sandrine</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Bacteriology Department, CHU Sud, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Josse</LastName>
            <ForeName>Françoise</ForeName>
            <Initials>F</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, GH Est, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guillot</LastName>
            <ForeName>Xavier</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, CHU Nord, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Poubeau</LastName>
            <ForeName>Patrice</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Internal Medicine and Dermatology, CHU Sud, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moiton</LastName>
            <ForeName>Marie-Pierre</ForeName>
            <Initials>MP</Initials>
            <AffiliationInfo>
              <Affiliation>Infectious Disease Department, CHU Nord, La Réunion, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Bertolotti</LastName>
            <ForeName>Antoine</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Infectious Disease, Internal Medicine and Dermatology, CHU Sud, La Réunion, France.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Inserm CIC 1410, Saint-Pierre, Réunion Island, France.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raffray</LastName>
            <ForeName>Loïc</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Internal Medicine Department, CHU Nord, La Réunion, France. loic.raffray@chu-reunion.fr.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Université de La Réunion, UMR PIMIT, CHU de La RéunionUnité Mixte Processus Infectieux en Milieu Insulaire Tropical (PIMIT), Plateforme Technologique CYROI, INSERM U1187, IRD 249 Sainte-Clotilde, CNRS 9192, La Réunion, France. loic.raffray@chu-reunion.fr.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Service de Médecine Interne, CHU Félix Guyon, Allée des Topazes, 97400, Saint Denis, France. loic.raffray@chu-reunion.fr.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>05</Month>
          <Day>20</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>Germany</Country>
        <MedlineTA>Clin Rheumatol</MedlineTA>
        <NlmUniqueID>8211469</NlmUniqueID>
        <ISSNLinking>0770-3198</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Bacterial arthritis</Keyword>
        <Keyword MajorTopicYN="N">Gonococcus</Keyword>
        <Keyword MajorTopicYN="N">Neisseria gonorrhoeae</Keyword>
        <Keyword MajorTopicYN="N">Tenosynovitis</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>17</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>19</Day>
          <Hour>23</Hour>
          <Minute>39</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>20</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>aheadofprint</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35590115</ArticleId>
        <ArticleId IdType="doi">10.1007/s10067-022-06208-w</ArticleId>
        <ArticleId IdType="pii">10.1007/s10067-022-06208-w</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Janier M (2016) Recommandations diagnostiques et thérapeutiques des IST, Société Française de Dermatologie. Ann Dermatol Vénéréologie 143(11):701–702</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annder.2016.09.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, al. (2019) Gonorrhoea. Nat Rev Dis Primer 5(1):1–23. https://doi.org/10.1038/s41572-019-0128-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41572-019-0128-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bardin T (2003) Gonococcal arthritis. Best Pract Res Clin Rheumatol 17(2):201–208. https://doi.org/10.1016/S1521-6942(02)00125-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1521-6942(02)00125-0</ArticleId>
            <ArticleId IdType="pubmed">12787521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eisenstein BI, Masi AT (1981) Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): I. Bacteriology, epidemiology, host factors pathogen factors, and pathology. Semin Arthritis Rheum 10(3):155–72. https://doi.org/10.1016/S0049-0172(81)80001-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0049-0172(81)80001-7</ArticleId>
            <ArticleId IdType="pubmed">6112797</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Belkacemal. A (2013) Changing patterns of disseminated gonococcal infection in France: cross-sectional data 2009–2011. Sex Transm Infect 89(8):613–615. https://doi.org/10.1136/sextrans-2013-051119</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/sextrans-2013-051119</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Birrell JM and al (2019) Characteristics and impact of disseminated gonococcal infection in the “top end” of Australia. Am J Trop Med Hyg 101(4):753–760. https://doi.org/10.4269/ajtmh.19-0288</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4269/ajtmh.19-0288</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tuttle CSL and al (2015) The epidemiology of gonococcal arthritis in an Indigenous Australian population. Sex Transm Infect 91(7):497–501. https://doi.org/10.1136/sextrans-2014-051893</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/sextrans-2014-051893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wise CM and al (1994) Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985–1991). Arch Intern Med 154(23):2690–5. https://doi.org/10.1001/archinte.1994.00420230077009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/archinte.1994.00420230077009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Brien JP and al (1983) Disseminated gonococcal infection: a prospective analysis of 49 patients and a review of pathophysiology and immune mechanisms. Medicine (Baltimore) 62(6):395–406</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/00005792-198311000-00005</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nossent J and al (2020) Septic arthritis due to Neisseria gonorrhoea in Western Australia. Intern Med J. https://doi.org/10.1111/imj.15169</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/imj.15169</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pérès S and al (1988) Gonococcal infections of the joints. Rev Med Interne 9(2):167–171. https://doi.org/10.1016/s0248-8663(88)80116-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0248-8663(88)80116-4</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ngangro NN and al (2019) Bacterial sexually transmitted infections in France: recent trends and patients’ characteristics in 2016. Eurosurveillance 24(5):1800038. https://doi.org/10.2807/1560-7917.ES.2019.24.5.1800038</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2807/1560-7917.ES.2019.24.5.1800038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>La Ruche G and al (2015) Incidence of gonococcal and chlamydial infections and coverage of two laboratory surveillance networks, France, 2012. Euro Surveill 20(32):6–15</Citation>
        </Reference>
        <Reference>
          <Citation>World Health Organization, Reproductive Health and Research. (2016) WHO guidelines for the treatment of Neisseria gonorrhoeae. http://www.ncbi.nlm.nih.gov/books/NBK379221/ Accessed 8 Feb 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Newman L and al (2015) Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS ONE 10(12):e0143304. https://doi.org/10.1371/journal.pone.0143304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0143304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Costa-Lourenço and al (2017) Antimicrobial resistance in Neisseria gonorrhoeae: history, molecular mechanisms and epidemiological aspects of an emerging global threat. Braz J Microbiol 48(4):617–628. https://doi.org/10.1016/j.bjm.2017.06.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bjm.2017.06.001</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bolan GA, Sparling PF, Wasserheit JN (2012) The emerging threat of untreatable gonococcal infection. N Engl J Med 366(6):485–487. https://doi.org/10.1056/NEJMp1112456</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMp1112456</ArticleId>
            <ArticleId IdType="pubmed">22316442</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Unemo M, Golparian D, Eyre DW (2019) Antimicrobial resistance in Neisseria gonorrhoeae and treatment of gonorrhea. Methods Mol Biol 1997:37–58. https://doi.org/10.1007/978-1-4939-9496-0_3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/978-1-4939-9496-0_3</ArticleId>
            <ArticleId IdType="pubmed">31119616</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Delfosse Aand al (2021) High prevalence of syphilis in women, minors and precarious patients: a cross-sectional study in a Reunion Island sexually transmitted infection clinic, 2017–2020. J Eur Acad Dermatol Venereol 35(11):2287–2292. https://doi.org/10.1111/jdv.17572</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Begnis R and al (2021) Prevalence and risk factors of Mycoplasma genitalium infection in patients attending a sexually transmitted infection clinic in Reunion Island: a cross-sectional study (2017–2018). BMC Infect Dis 21(1):482. https://doi.org/10.1186/s12879-021-06193-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12879-021-06193-6</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Etienne A and al (2021) Increase in early syphilis diagnoses in the young heterosexual population of Reunion Island: surveillance data, 2010–2018. J Eur Acad Dermatol Venereol 35(9):e573–e575. https://doi.org/10.1111/jdv.17294</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jdv.17294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Folio M and al (2021) Minors are the most affected by Chlamydia trachomatis in Reunion Island: a cross-sectional study, 2017–2018. Ann Dermatol Venereol 148(4):238–240. https://doi.org/10.1016/j.annder.2021.02.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annder.2021.02.007</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Saib A and al (2020) Prévalence et facteurs de risque de l’infection à gonocoque en centre de dépistage à la Réunion, une étude transversale multicentrique. Ann Dermatol Vénéréologie 147:A287</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.annder.2020.09.419</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kutzbach and al (1974) (1974) Identification of Neisseria gonorrhoeae in synovial membrane by electron microscopy. J Infect Dis 130(2):183–186. https://doi.org/10.1093/infdis/130.2.183</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/130.2.183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Population par sexe et groupe d’âges | Insee. https://www.insee.fr/fr/statistiques/2381474 Accessed 25 Nov 2020</Citation>
        </Reference>
        <Reference>
          <Citation>SPF. Bulletin de santé publique VIH-IST à La Réunion. Novembre 2019. https://www.santepubliquefrance.fr/regions/ocean-indien/documents/bulletin-regional/2019/bulletin-de-sante-publique-vih-ist-a-la-reunion.-novembre-2019 Accessed 13 Aug 2021</Citation>
        </Reference>
        <Reference>
          <Citation>Yu KH and al (2003) Concomitant septic and gouty arthritis—an analysis of 30 cases. Rheumatology (Oxford) 42(9):1062–1066. https://doi.org/10.1093/rheumatology/keg297</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/rheumatology/keg297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beauté J and al (2017) Travel-associated gonorrhoea in four Nordic countries, 2008 to 2013. Euro Surveill 22(20). https://doi.org/10.2807/1560-7917.ES.2017.22.20.30537</Citation>
        </Reference>
        <Reference>
          <Citation>Tapsall JW, Phillips EA, Shultz TR, Way B, Withnall K (1992) Strain characteristics and antibiotic susceptibility of isolates of Neisseria gonorrhoeae causing disseminated gonococcal infection in Australia. Members of the Australian Gonococcal Surveillance Programme. Int J STD AIDS 3(4):273–7. https://doi.org/10.1177/095646249200300408</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/095646249200300408</ArticleId>
            <ArticleId IdType="pubmed">1504159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roth A, Mattheis C, Muenzner P, Unemo M, Hauck CR (2013) Innate recognition by neutrophil granulocytes differs between Neisseria gonorrhoeae strains causing local or disseminating infections. Infect Immun 81(7):2358–2370. https://doi.org/10.1128/IAI.00128-13</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00128-13</ArticleId>
            <ArticleId IdType="pubmed">23630956</ArticleId>
            <ArticleId IdType="pmc">3697628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rice PA (2005) Gonococcal arthritis (disseminated gonococcal infection). Infect Dis Clin North Am 19(4):853–861. https://doi.org/10.1016/j.idc.2005.07.003</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.idc.2005.07.003</ArticleId>
            <ArticleId IdType="pubmed">16297736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Masi AT, Eisenstein BI (1981) Disseminated gonococcal infection (DGI) and gonococcal arthritis (GCA): II. Clinical manifestations, diagnosis, complications, treatment, and prevention. Semin Arthritis Rheum 10(3):173–97. https://doi.org/10.1016/s0049-0172(81)80002-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0049-0172(81)80002-9</ArticleId>
            <ArticleId IdType="pubmed">6785887</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poncin T, Bercot B (2019) Le gonocoque: le point en 2018. Rev Biol Médicale 327:13</Citation>
        </Reference>
        <Reference>
          <Citation>Nolla JM and al (2015) Pyogenic arthritis of native joints in non-intravenous drug users: a detailed analysis of 268 cases attended in a tertiary hospital over a 22-year period. Semin Arthritis Rheum 45(1):94–102. https://doi.org/10.1016/j.semarthrit.2015.01.009</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.semarthrit.2015.01.009</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McBride S and al (2020) Epidemiology, management, and outcomes of large and small native joint septic arthritis in adults. Clin Infect Dis Off Publ Infect Dis Soc Am 70(2):271–279. https://doi.org/10.1093/cid/ciz265</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/ciz265</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
